2020
DOI: 10.1186/s13059-020-02148-3
|View full text |Cite
|
Sign up to set email alerts
|

Variation around the dominant viral genome sequence contributes to viral load and outcome in patients with Ebola virus disease

Abstract: Background Viral load is a major contributor to outcome in patients with Ebola virus disease (EVD), with high values leading to a fatal outcome. Evidence from the 2013–2016 Ebola virus (EBOV) outbreak indicated that different genotypes of the virus can have different phenotypes in patients. Additionally, due to the error-prone nature of viral RNA synthesis in an individual patient, the EBOV genome exists around a dominant viral genome sequence. The minor variants within a patient may contribute to the overall … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
40
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
4
3

Relationship

6
1

Authors

Journals

citations
Cited by 20 publications
(40 citation statements)
references
References 51 publications
0
40
0
Order By: Relevance
“…Individual variations can be selected if they are advantageous or through founder effect or a mixture of both. In viruses with significant deletions in proteins, or the presence of stop codons, reported at a consensus sequence level, these may be balanced within the virus population with the presence of functional proteins at a minor variant level, similar to that observed in Ebola virus infection in humans [185].…”
Section: Discussionmentioning
confidence: 66%
See 1 more Smart Citation
“…Individual variations can be selected if they are advantageous or through founder effect or a mixture of both. In viruses with significant deletions in proteins, or the presence of stop codons, reported at a consensus sequence level, these may be balanced within the virus population with the presence of functional proteins at a minor variant level, similar to that observed in Ebola virus infection in humans [185].…”
Section: Discussionmentioning
confidence: 66%
“…Individual variations can be selected if they are advantageous or through founder effect or a mixture of both. In viruses with significant deletions in proteins, or the presence of stop codons, reported at a consensus sequence level, these may be balanced within the virus population with the presence of functional proteins at a minor variant level, similar to that observed in Ebola virus infection in humans [ 185 ]. Deep sequencing of clinical isolates can reveal important cooperative interactions between members of the virus population within a single host, and a better understanding of transmission bottlenecks will allow us to understand whether such interactions are perpetuated in transmission chains.…”
Section: Discussionmentioning
confidence: 98%
“…The minor variant population in infections has been shown to influence the kinetics of virus replication and be associated with patient outcome ( 36 ). Therefore, methodologies were developed that could be used to assess the minor variant frequency within a sample from a patient infected with MERS-CoV.…”
Section: Resultsmentioning
confidence: 99%
“…This potential disconnect is not restricted to SARS-CoV-2. The balance between consensus and minor variants and the presence of stop codons in virus populations within individual patients has been shown to influence the activity of the Ebola virus RNA dependent RNA polymerase and correlate with outcome in patients with Ebola virus disease (21). Within an individual person with SARS-CoV-2, these mixtures of functioning and presumably non-functioning viral proteins will potentially influence viral load.…”
Section: Discussionmentioning
confidence: 99%